Deutsche Bank lowers its price target on MedAssets (Nasdaq: MDAS) from $25 to $22.50, but maintains its Buy rating, following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE